The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Adrenocortical Carcinoma

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Adrenocortical Carcinoma


High impact information on Adrenocortical Carcinoma


Chemical compound and disease context of Adrenocortical Carcinoma


Biological context of Adrenocortical Carcinoma


Anatomical context of Adrenocortical Carcinoma


Gene context of Adrenocortical Carcinoma


Analytical, diagnostic and therapeutic context of Adrenocortical Carcinoma


  1. Multiple hormone receptors in the adenylate cyclase of human adrenocortical tumors. Matsukura, S., Kakita, T., Sueoka, S., Yoshimi, H., Hirata, Y., Yokota, M., Fujita, T. Cancer Res. (1980) [Pubmed]
  2. Phase II trial of mitotane and cisplatin in patients with adrenal carcinoma: a Southwest Oncology Group study. Bukowski, R.M., Wolfe, M., Levine, H.S., Crawford, D.E., Stephens, R.L., Gaynor, E., Harker, W.G. J. Clin. Oncol. (1993) [Pubmed]
  3. Adrenocortical carcinoma. An immunohistochemical comparison with renal cell carcinoma. Wick, M.R., Cherwitz, D.L., McGlennen, R.C., Dehner, L.P. Am. J. Pathol. (1986) [Pubmed]
  4. Association of H19 promoter methylation with the expression of H19 and IGF-II genes in adrenocortical tumors. Gao, Z.H., Suppola, S., Liu, J., Heikkilä, P., Jänne, J., Voutilainen, R. J. Clin. Endocrinol. Metab. (2002) [Pubmed]
  5. Insulin-like growth factors (IGFs) and their receptors in adrenal tumors: high IGF-II expression in functional adrenocortical carcinomas. Ilvesmäki, V., Kahri, A.I., Miettinen, P.J., Voutilainen, R. J. Clin. Endocrinol. Metab. (1993) [Pubmed]
  6. Mitotane therapy of adrenocortical carcinoma. Haak, H.R., van Seters, A.P., Moolenaar, A.J. N. Engl. J. Med. (1990) [Pubmed]
  7. High frequency of germline p53 mutations in childhood adrenocortical cancer. Wagner, J., Portwine, C., Rabin, K., Leclerc, J.M., Narod, S.A., Malkin, D. J. Natl. Cancer Inst. (1994) [Pubmed]
  8. Detection of novel germ-line p53 mutations in diverse-cancer-prone families identified by selecting patients with childhood adrenocortical carcinoma. Sameshima, Y., Tsunematsu, Y., Watanabe, S., Tsukamoto, T., Kawa-ha, K., Hirata, Y., Mizoguchi, H., Sugimura, T., Terada, M., Yokota, J. J. Natl. Cancer Inst. (1992) [Pubmed]
  9. Genetic changes in human adrenocortical carcinomas. Yano, T., Linehan, M., Anglard, P., Lerman, M.I., Daniel, L.N., Stein, C.A., Robertson, C.N., LaRocca, R., Zbar, B. J. Natl. Cancer Inst. (1989) [Pubmed]
  10. Ectopic beta-adrenergic receptor binding sites. possible molecular basis of aberrant catecholamine responsiveness of an adrenocortical tumor adenylate cyclase. Williams, L.T., Gore, T.B., Lefkowitz, R.J. J. Clin. Invest. (1977) [Pubmed]
  11. Suramin for treatment of adrenocortical carcinoma. Allolio, B., Reincke, M., Arlt, W., Deuss, U., Winkelmann, W., Siekmann, L. Lancet (1989) [Pubmed]
  12. Transplacental carcinogenesis (adrenocortical carcinoma) associated with hydroxyprogesterone hexanoate. Mann, J.R., Cameron, A.H., Gornall, P., Rayner, P.H., Shah, K.J. Lancet (1983) [Pubmed]
  13. Aldosterone-producing adrenocortical carcinoma. Preoperative recognition and course in three cases. Arteaga, E., Biglieri, E.G., Kater, C.E., Lopez, J.M., Schambelan, M. Ann. Intern. Med. (1984) [Pubmed]
  14. Expression of autophosphorylating protein kinase 500 in normal and neoplastic rat cells. Majumdar, G., Cashel, M., Sharma, R.K. Proc. Natl. Acad. Sci. U.S.A. (1985) [Pubmed]
  15. Inhibition of tumorigenesis by a cytosine-DNA, methyltransferase, antisense oligodeoxynucleotide. Ramchandani, S., MacLeod, A.R., Pinard, M., von Hofe, E., Szyf, M. Proc. Natl. Acad. Sci. U.S.A. (1997) [Pubmed]
  16. Steroid 21-hydroxylase mutations and 21-hydroxylase messenger ribonucleic acid expression in human adrenocortical tumors. Beuschlein, F., Schulze, E., Mora, P., Gensheimer, H.P., Maser-Gluth, C., Allolio, B., Reincke, M. J. Clin. Endocrinol. Metab. (1998) [Pubmed]
  17. Prevalence of HLA-DRB1 genotype and altered Fas/Fas ligand expression in adrenocortical carcinoma. Wolkersdörfer, G.W., Marx, C., Brown, J., Schröder, S., Füssel, M., Rieber, E.P., Kuhlisch, E., Ehninger, G., Bornstein, S.R. J. Clin. Endocrinol. Metab. (2005) [Pubmed]
  18. The role of the insulin-like growth factor system in adrenocortical tumourigenesis. Weber, M.M., Fottner, C., Wolf, E. Eur. J. Clin. Invest. (2000) [Pubmed]
  19. Hypermineralocorticism without excessive aldosterone secretion: an adrenal carcinoma producing deoxycorticosterone. Kelly, W.F., O'Hare, M.J., Loizou, S., Davies, D., Laing, I. Clin. Endocrinol. (Oxf) (1982) [Pubmed]
  20. Establishment and characterization of a human adrenocortical carcinoma cell line that expresses multiple pathways of steroid biosynthesis. Gazdar, A.F., Oie, H.K., Shackleton, C.H., Chen, T.R., Triche, T.J., Myers, C.E., Chrousos, G.P., Brennan, M.F., Stein, C.A., La Rocca, R.V. Cancer Res. (1990) [Pubmed]
  21. Expression of neural cell adhesion molecule in normal and neoplastic human neuroendocrine tissues. Jin, L., Hemperly, J.J., Lloyd, R.V. Am. J. Pathol. (1991) [Pubmed]
  22. Suprarenal vena caval occlusion. Principles of operative management. Smith, B.M., Mulherin, J.L., Sawyers, J.L., Turner, B.I., Prager, R.L., Dean, R.H. Ann. Surg. (1984) [Pubmed]
  23. Ectopic beta-adrenergic receptors coupled to adenylate cyclase in human adrenocortical carcinomas. Katz, M.S., Kelly, T.M., Dax, E.M., Pineyro, M.A., Partilla, J.S., Gregerman, R.I. J. Clin. Endocrinol. Metab. (1985) [Pubmed]
  24. Angiotensin II promotes selective uptake of high density lipoprotein cholesterol esters in bovine adrenal glomerulosa and human adrenocortical carcinoma cells through induction of scavenger receptor class B type I. Cherradi, N., Bideau, M., Arnaudeau, S., Demaurex, N., James, R.W., Azhar, S., Capponi, A.M. Endocrinology (2001) [Pubmed]
  25. Decreased expression of cyclic adenosine monophosphate-regulated aldose reductase (AKR1B1) is associated with malignancy in human sporadic adrenocortical tumors. Lefrançois-Martinez, A.M., Bertherat, J., Val, P., Tournaire, C., Gallo-Payet, N., Hyndman, D., Veyssière, G., Bertagna, X., Jean, C., Martinez, A. J. Clin. Endocrinol. Metab. (2004) [Pubmed]
  26. Transforming growth factor alpha, epidermal growth factor, and epidermal growth factor receptor expression in normal and diseased human adrenal cortex by immunohistochemistry and in situ hybridization. Sasano, H., Suzuki, T., Shizawa, S., Kato, K., Nagura, H. Mod. Pathol. (1994) [Pubmed]
  27. Loss of growth hormone secretagogue receptor 1a and overexpression of type 1b receptor transcripts in human adrenocortical tumors. Barzon, L., Pacenti, M., Masi, G., Stefani, A.L., Fincati, K., Palù, G. Oncology (2005) [Pubmed]
  28. Molecular analysis of CDKN1C and TP53 in sporadic adrenal tumors. Barzon, L., Chilosi, M., Fallo, F., Martignoni, G., Montagna, L., Palù, G., Boscaro, M. Eur. J. Endocrinol. (2001) [Pubmed]
  29. Localization and expression of adrenocorticotropic hormone receptor mRNA in normal and neoplastic human adrenal cortex. Reincke, M., Beuschlein, F., Menig, G., Hofmockel, G., Arlt, W., Lehmann, R., Karl, M., Allolio, B. J. Endocrinol. (1998) [Pubmed]
  30. Expression and regulation of the lipoprotein lipase gene in human adrenal cortex. Staels, B., Martin, G., Martinez, M., Albert, C., Peinado-Onsurbe, J., Saladin, R., Hum, D.W., Reina, M., Vilaro, S., Auwerx, J. J. Biol. Chem. (1996) [Pubmed]
  31. Scintigraphic detection of hepatic metastases with 131I-labeled steroid in recurrent adrenal carcinoma: case report. Watanabe, K., Kamoi, I., Nakayama, C., Koga, I., Matsuura, K. J. Nucl. Med. (1976) [Pubmed]
  32. Establishment and characterization of a human adrenocortical carcinoma xenograft model. Logié, A., Boudou, P., Boccon-Gibod, L., Baudin, E., Vassal, G., Schlumberger, M., Le Bouc, Y., Gicquel, C. Endocrinology (2000) [Pubmed]
  33. Overlapping expression of immunohistochemical markers and synaptophysin mRNA in pheochromocytomas and adrenocortical carcinomas. Implications for the differential diagnosis of adrenal gland tumors. Komminoth, P., Roth, J., Schröder, S., Saremaslani, P., Heitz, P.U. Lab. Invest. (1995) [Pubmed]
  34. Recovery of adrenal function after treatment of adrenocortical carcinoma with o,p'-DDD. Greig, F., Oberfield, S.E., Levine, L.S., Ghavimi, F., Pang, S., New, M.I. Clin. Endocrinol. (Oxf) (1984) [Pubmed]
WikiGenes - Universities